WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Rodman & Renshaw 8th Annual Healthcare Conference 2006 on November 6, 2006 in New York City. President and CEO, Steven Rauscher, will provide an overview of the Company including details on the acquisition of ANTARA(R) 130 mg (fenofibrate) capsules and preparation for the third winter season for FACTIVE(R) (gemifloxacin mesylate) tablets.
